These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 34886779)
1. Therapeutic Effects of Physical Exercise and the Mesenchymal Stem Cell Secretome by Modulating Neuroinflammatory Response in Multiple Sclerosis. González LM; Ospina LN; Sperling LE; Chaparro O; Cucarián JD Curr Stem Cell Res Ther; 2022; 17(7):621-632. PubMed ID: 34886779 [TBL] [Abstract][Full Text] [Related]
2. Effects of mesenchymal stem cells transplantation on multiple sclerosis patients. Barati S; Tahmasebi F; Faghihi F Neuropeptides; 2020 Dec; 84():102095. PubMed ID: 33059244 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies. Gugliandolo A; Bramanti P; Mazzon E Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212873 [TBL] [Abstract][Full Text] [Related]
4. Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis. Sarkar P; Redondo J; Kemp K; Ginty M; Wilkins A; Scolding NJ; Rice CM Cytotherapy; 2018 Jan; 20(1):21-28. PubMed ID: 28917625 [TBL] [Abstract][Full Text] [Related]
5. Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation. Abbasi-Kangevari M; Ghamari SH; Safaeinejad F; Bahrami S; Niknejad H Front Immunol; 2019; 10():238. PubMed ID: 30842772 [TBL] [Abstract][Full Text] [Related]
6. The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties. Gavasso S; Kråkenes T; Olsen H; Evjenth EC; Ytterdal M; Haugsøen JB; Kvistad CE Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338644 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials. Ghasemi M; Roshandel E; Mohammadian M; Farhadihosseinabadi B; Akbarzadehlaleh P; Shamsasenjan K Stem Cell Res Ther; 2023 May; 14(1):122. PubMed ID: 37143147 [TBL] [Abstract][Full Text] [Related]
9. The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis. Dadfar S; Yazdanpanah E; Pazoki A; Nemati MH; Eslami M; Haghmorad D; Oksenych V Cells; 2024 Sep; 13(18):. PubMed ID: 39329740 [TBL] [Abstract][Full Text] [Related]
10. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease. Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785 [TBL] [Abstract][Full Text] [Related]
11. Neural stem cells derived from primitive mesenchymal stem cells reversed disease symptoms and promoted neurogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Brown C; McKee C; Halassy S; Kojan S; Feinstein DL; Chaudhry GR Stem Cell Res Ther; 2021 Sep; 12(1):499. PubMed ID: 34503569 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis. Xiao J; Yang R; Biswas S; Qin X; Zhang M; Deng W Int J Mol Sci; 2015 Apr; 16(5):9283-302. PubMed ID: 25918935 [TBL] [Abstract][Full Text] [Related]
13. Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity. Vaes JEG; van Kammen CM; Trayford C; van der Toorn A; Ruhwedel T; Benders MJNL; Dijkhuizen RM; Möbius W; van Rijt SH; Nijboer CH Glia; 2021 Mar; 69(3):655-680. PubMed ID: 33045105 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells and their derived exosomes in multiple sclerosis disease: from paper to practice. Hamidi SH; Etebar N; Rahimzadegan M; Zali A; Roodsari SR; Niknazar S Mol Cell Biochem; 2024 Jul; 479(7):1643-1671. PubMed ID: 38977625 [TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. Cunningham CJ; Redondo-Castro E; Allan SM J Cereb Blood Flow Metab; 2018 Aug; 38(8):1276-1292. PubMed ID: 29768965 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of human embryonic stem cell-derived mesenchymal stem cells secretome preconditioned with diazoxide, trimetazidine and MG-132 on LPS-induced systemic inflammation mouse model. Jahandideh S; Khatami S; Eslami Far A; Kadivar M Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1178-1187. PubMed ID: 29929400 [TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis. Kråkenes T; Sandvik CE; Ytterdal M; Gavasso S; Evjenth EC; Bø L; Kvistad CE Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408622 [TBL] [Abstract][Full Text] [Related]
18. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease. d'Angelo M; Cimini A; Castelli V Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092 [TBL] [Abstract][Full Text] [Related]
19. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease. Driscoll J; Patel T J Gastroenterol; 2019 Sep; 54(9):763-773. PubMed ID: 31270691 [TBL] [Abstract][Full Text] [Related]
20. A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time! Siatskas C; Payne NL; Short MA; Bernard CC Stem Cell Rev Rep; 2010 Dec; 6(4):500-6. PubMed ID: 20665128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]